SCHEMBL31676543

SCHEMBL31676543

C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(=O)O)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ NMT1 P30419 4/20 0.45
▸ NMT2 O60551 3/20 0.45
▸ EGFR P00533 1/20 0.44
▸ FOLH1 Q04609 1/20 0.43
▸ GLO1 Q04760 1/20 0.41
▸ BACE1 P56817 2/20 0.41
▸ CTSD P07339 1/20 0.41
▸ PTGS1 P23219 1/20 0.41
▸ GSTK1 Q9Y2Q3 1/20 0.41
▸ DPP4 P27487 1/20 0.40
▸ DPP8 Q6V1X1 1/20 0.40
▸ DPP9 Q86TI2 1/20 0.40
▸ OPRD1 P41143 3/20 0.39
▸ OPRM1 P35372 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31676576 0.99 EGFR (0.45) NMT1NMT2EGFRFOLH1GLO1
SCHEMBL31676589 0.95 FOLH1 (0.50) NMT1NMT2EGFRFOLH1GLO1
SCHEMBL29777771 0.95 FOLH1 (0.50) NMT1NMT2EGFRFOLH1GLO1
SCHEMBL29777838 0.95 FOLH1 (0.50) NMT1NMT2EGFRFOLH1GLO1
SCHEMBL31676603 0.95 FOLH1 (0.49) NMT1NMT2EGFRFOLH1GLO1
SCHEMBL30148958 0.94 FOLH1 (0.46) NMT1NMT2EGFRFOLH1GLO1
SCHEMBL31676592 0.93 NMT2 (0.43) NMT1NMT2EGFRFOLH1GLO1
SCHEMBL31676561 0.93 FOLH1 (0.50) NMT1NMT2EGFRFOLH1GLO1
SCHEMBL29777769 0.93 FOLH1 (0.50) NMT1NMT2EGFRFOLH1GLO1
SCHEMBL31676647 0.92 FOLH1 (0.51) NMT1NMT2EGFRFOLH1GLO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250263437-A1 POLYPEPTIDE FOR REPAIRING SKIN WOUND OR MUCOSAL INJURY, AND APPLICATION THEREOF SICHUAN GOODDOCTOR PANXI PHARMACEUTICAL CO., LTD. (CN) 2025-08-21 — — US disclosed
Send feedback